Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

HDM1005

Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus

Huadong Medicine · Phase 2 · Recruiting · Enrollment 240

NCT06886126

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
HDM1005 dose cohort 1 QWn/rn/rn/rn/r
HDM1005 dose cohort 2 QWn/rn/rn/rn/r
HDM1005 dose cohort 3 QWn/rn/rn/rn/r
HDM1005 dose cohort 4 QWn/rn/rn/rn/r
placebo QWn/rn/rn/rn/r

Not shown

  • HDM1005 dose cohort 1 QW: endpoint not reported
  • HDM1005 dose cohort 2 QW: endpoint not reported
  • HDM1005 dose cohort 3 QW: endpoint not reported
  • HDM1005 dose cohort 4 QW: endpoint not reported
  • placebo QW: endpoint not reported